Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: A single center experience

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 5, 2013, Pages 782-785

  Bratincsák, András ^a,b   Moore, John W ^a,b   El Said, Howaida G ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

catheterization; tissue plasminogen activator; vascular thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ARTERY THROMBOSIS; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CHILD; CLINICAL ARTICLE; DOPPLER FLOWMETRY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMORAL ARTERY THROMBOSIS; FEMORAL VEIN THROMBOSIS; HEART CATHETERIZATION; HEPARINIZATION; HUMAN; LOW DRUG DOSE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT; VEIN THROMBOSIS;

CATHETERIZATION; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR THROMBOSIS;

AGE FACTORS; CALIFORNIA; CARDIAC CATHETERIZATION; DRUG DOSAGE CALCULATIONS; FEMORAL ARTERY; FEMORAL VEIN; FIBRINOLYTIC AGENTS; HEALTH CARE SURVEYS; HUMANS; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; THROMBOSIS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR; VENOUS THROMBOSIS;

EID: 84886949282     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24521     Document Type: Article

References (12)

1. Freed MD, Keane JF, Rosenthal A,. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation 1974; 50: 565-569.
2. Manco-Johnson MJ, Nuss R, Hays T, et al. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr 2000; 136: 425-426.
3. Collen D, Lijnen HR,. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78: 3114-3124.
4. Bergmann SR, Fox KA, Ter-Pogossian MM, et al. Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science 1983; 220: 1181-1183.
5. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med 1985; 312: 932-940.
6. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: Randomized trial assessing right ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-512.
7. The NINDS rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
8. Zenz W, Muntean W, Beitzke A, et al. Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterization in infants and children. Br Heart J 1993; 70: 382-385.
9. Wang M, Hays T, Balasa V, et al. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol 2003; 25: 379-386.
10. Carlson KM, Rutledge BR, Parker BR, Grifka RG,. Use of tissue plasminogen activator for femoral artery thrombosis following transcatheter coil occlusion of patent ductus arteriosus. Pediatr Cardiol 2005; 26: 83-86.
11. Monagle P, Michelson AD, Bovill E, Andrew M,. Antithrombotic therapy in children. Chest 2001; 119: 322S-370S.
12. Brus F, Witsenburg M, Hofhuis WJD, et al. Streptokinase treatment for femoral artery thrombosis after arterial cardiac catheterization in infants and children. Br Heart J 1990; 63: 291-294.